PetVivo Holdings, Inc. (PETV) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US7168174081
PetVivo Holdings, Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 1.13 m USD | 1.14 m USD |
| Gross profit | 994,856.00 USD | 754,751.00 USD |
| Operating income | -8.06 m USD | -9.06 m USD |
| EBIT | -8.40 m USD | -10.47 m USD |
| Net income | -8.40 m USD | -10.47 m USD |
| Diluted EPS – continuing operations | -0.41 USD | -0.38 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. The company is based in Edina, Minnesota.
More stocks
- BuzzFeed, Inc. (BZFD)
- Western Uranium & Vanadium Corp. (WSTRF)
- Eva Live Inc (GOAI)
- Crisp Momentum Inc. (CRSF)
- Karbon-X Corp. (KARX)
- ATOSSA THERAPEUTICS, INC. (ATOS)
- BioInvent International AB (BINV.ST)
- Sun Pacific Holding Corp. (SNPW)
- SolarMax Technology, Inc. (SMXT)
- REED'S, INC. (REED)
- AYTU BIOPHARMA, INC (AYTU)
- FULL HOUSE RESORTS INC (FLL)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.